BAX Baxter International Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BAX

Price (delayed)

$27.68

Market cap

$14.31B

P/E Ratio

N/A

Dividend/share

$0.2

EPS

-$2.08

Enterprise value

$21.83B

?
Relative Growth: Rel. Growth: 26
Relative Strength: Rel. Strength: 85
Relative Valuation: Rel. Valuation: 31
Relative Profitability: Rel. Profitability: 18

Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees ...

Highlights
The revenue is up by 5% year-on-year
BAX's net income is up by 3.2% since the previous quarter
The company's equity fell by 15% YoY but it rose by 2.7% QoQ
The quick ratio is up by 11% since the previous quarter but it is down by 5% year-on-year
The gross margin is down by 15% year-on-year
The gross profit has declined by 10% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.baxter.com
Peers: CAH BSX SYK BDX

Key stats

What are the main financial stats of BAX

BAX stock price

How has the Baxter International stock price performed over time
Intraday
5.81%
1 week
18.59%
1 month
22.21%
1 year
26.05%
YTD
44.85%
QTD
29.83%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$11.47B
Gross profit
$3.45B
Operating income
-$274M
Net income
-$1.06B
Gross margin
30.1%
Net margin
-9.3%
The gross margin is down by 15% year-on-year
The operating margin has increased by 11% from the previous quarter
The gross profit has declined by 10% year-on-year
Baxter International's operating income has increased by 9% from the previous quarter

Price vs fundamentals

How does BAX's price correlate with its fundamentals

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
BAX P/E details
P/E
N/A
P/B
2.3
P/S
1.25
EV/EBIT
N/A
EV/EBITDA
35.15
EV/Sales
1.9
The EPS has grown by 2.8% from the previous quarter
BAX's P/B is 36% above its last 4 quarters average of 1.6 but 27% below its 5-year quarterly average of 3.0
The company's equity fell by 15% YoY but it rose by 2.7% QoQ
BAX's P/S is 38% below its 5-year quarterly average of 1.9 but 31% above its last 4 quarters average of 0.9
The revenue is up by 5% year-on-year

Efficiency

How efficient is Baxter International business performance
The ROS has grown by 15% from the previous quarter
The ROIC has increased by 12% from the previous quarter

Dividends

What is BAX's dividend history
Dividend details
DPS
$0.2
Dividend yield
0.72%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Baxter International financials performed over time
The total assets is 45% more than the total liabilities
The current ratio fell by 15% YoY but it rose by 5% QoQ
The quick ratio is up by 11% since the previous quarter but it is down by 5% year-on-year
Baxter International's debt is 56% more than its equity
The debt to equity has increased by 17% year-on-year but it has declined by 2.5% since the previous quarter
The company's equity fell by 15% YoY but it rose by 2.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.